Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

NCT03373201 is registered in ClinicalTrials.gov with Vanda Pharmaceuticals as lead sponsor.

NCT NCT03373201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03373201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Lead sponsor
Vanda Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
October 16, 2017
Completion date
March 5, 2018
Enrollment
320 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

jet lag type insomnia